Clinical characteristics and outcomes of primary intracranial alveolar soft-part sarcoma: A case report

被引:0
作者
Chen, Jun-Yu [1 ]
Cen, Bo [1 ]
Hu, Fei [1 ]
Qiu, Yong [1 ]
Xiao, Guo-Min [1 ]
Zhou, Jun-Ge [1 ]
Zhang, Fang-Cheng [2 ]
机构
[1] Gen Hosp Yangtze River Shipping, Dept Neurosurg, Wuhan 430010, Hubei, Peoples R China
[2] Wuhan Union Hosp, Dept Neurosurg, 1277 Jiefang Ave, Wuhan 430010, Hubei, Peoples R China
关键词
Primary intracranial alveolar soft-part sarcoma; Surgery; Radiotherapy; Progression-free survival; Overall survival; Case report; BRAIN; METASTASIS; MANAGEMENT;
D O I
10.12998/wjcc.v10.i1.296
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Primary intracranial alveolar soft-part sarcoma (PIASPS) is a rare malignancy. We aimed to investigate the clinical profiles and outcomes for PIASPS. CASE SUMMARY We firstly reported five consecutive cases from our institute. Then, the cases from previous studies were pooled and analyzed to delineate the characteristics of this disease. Our cohort included two males and three females. The median age was 21-years-old (range: 8-54-years-old). All the patients received surgical treatment. Gross total resection (GTR), radiotherapy, and chemotherapy were administered in 3 patients, 4 patients, and 1 patient, respectively. After a median follow-up of 36 mo, tumor progression was noticed in 4 patients; and 3 patients died of the disease. Pooled data (n = 14) contained 5 males and 9 females with a median age of 19 years. The log-rank tests showed that GTR (P = 0.011) could prolong progression-free survival, and radiotherapy (P < 0.001) resulted in longer overall survival. CONCLUSION Patients with PIASPS suffer from poor outcomes. Surgical treatment is the first choice, and GTR should be achieved when the tumor is feasible. Patients with PIASPS benefit from radiotherapy, which should be considered as a part of treatment therapies.
引用
收藏
页码:296 / 303
页数:8
相关论文
共 50 条
  • [31] Alveolar soft part sarcoma of the pararectal space in the pelvic cavity: a case report and review of the literature
    Meng, Lian
    Dang, Hongwei
    Song, Lingxie
    Zhang, Pengpeng
    Du, Juan
    Du, Shutong
    Chen, Yunzhao
    Cui, Xiaobin
    Qi, Yan
    Liu, Chunxia
    Li, Feng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2017, 10 (07): : 11133 - 11139
  • [32] Alveolar Soft Part Sarcoma of the Tongue
    Baglam, Tekin
    Kalender, Mehmet Emin
    Durucu, Cengiz
    Bakir, Kemal
    Karatas, Erkan
    Kara, Ferit
    Kanlikama, Muzaffer
    JOURNAL OF CRANIOFACIAL SURGERY, 2009, 20 (06) : 2160 - 2162
  • [33] Successful treatment of advanced alveolar soft part sarcoma with camrelizumab combined with apatinib: a case report
    Xu, Zhen
    Zhang, Yong
    Yu, Yong-Hua
    ANNALS OF PALLIATIVE MEDICINE, 2021, 10 (01) : 785 - 792
  • [34] Alveolar soft part sarcoma: Clinical presentation, treatment, and outcome in a series of 13 patients
    Lin, Yu-Kuan
    Wu, Po-Kuei
    Chen, Cheng-Fong
    Chen, Chao-Ming
    Tsai, Shang-Wen
    Chen, Paul Chih-Hsueh
    Chen, Wei-Ming
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2018, 81 (08) : 735 - 741
  • [35] Primary intracranial synovial sarcoma with hemorrhage: A case report
    Wang, Yang-Yang
    Li, Man-Li
    Zhang, Zhi-Yong
    Ding, Jiang-Wei
    Xiao, Li-Fei
    Li, Wen-Chao
    Wang, Lei
    Sun, Tao
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (29) : 8871 - 8878
  • [36] Exploratory analysis of immunomodulatory factors identifies L1CAM as a prognostic marker in alveolar soft-part sarcoma
    Mondaza-Hernandez, Jose L.
    Hindi, Nadia
    Fernandez-Serra, Antonio
    Ramos, Rafael
    Gonzalez-Campora, Ricardo
    Gomez-Mateo, Maria Carmen
    Martinez-Trufero, Javier
    Lavernia, Javier
    Lopez-Pousa, Antonio
    Lainez, Nuria
    Martinez-Garcia, Jeronimo
    Valverde, Claudia
    Vaz-Salgado, Maria angeles
    Garcia-Plaza, Gabriel
    Marin-Borrero, Isabel
    Carrillo-Garcia, Jaime
    Martin-Ruiz, Marta
    Romero, Pablo
    Gutierrez, Antonio
    Lopez-Guerrero, Jose A.
    Moura, David S.
    Martin-Broto, Javier
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [37] Primary pulmonary alveolar soft part sarcoma with ASPSCR1-TFE3 gene fusion: Case report and literature review
    Hu, Xijian
    Chai, Jing
    Zhang, Bin
    Hu, Chengguang
    MEDICINE, 2024, 103 (44)
  • [38] Significance of immunohistochemistry and FISH of TFE3 in the diagnosis of alveolar soft part sarcoma: A case report
    Huang, Yan-Ying
    Yang, Wan-Rui
    Geng, Yan-Hua
    Zhang, Yue
    MEDICINE, 2022, 101 (27) : E29861
  • [39] Alveolar soft part sarcoma metastatic to the breast
    Hanna, NN
    ODonnell, K
    Wolfe, GRZ
    JOURNAL OF SURGICAL ONCOLOGY, 1996, 61 (02) : 159 - 162
  • [40] Alveolar soft part sarcoma metastasis to the choroid
    Pogrzebielski, Arkadiusz
    Oleksy, Piotr
    Orlowska-Heitzman, Jolanta
    Romanowska-Dixon, Bozena
    AMERICAN JOURNAL OF CASE REPORTS, 2010, 11 : 35 - 38